It has been a significant year doubling in size at ImaCor, as we have made great strides in building our clinical Advanced Hemodynamic Management programs. These programs positively impacted the care of thousands of multi-factorial, complex patients worldwide.
In 2014 we sought new ways to connect our customer's clinical and economic success, and shared best practices at symposia and in studies. We introduced engineering achievements like ImaCor's new high resolution imaging with "Point-in-Time" hemodynamic trending on our all-in-one hemodynamic management platform. We expanded and invested in our clinical sales team, and entered new markets around the world. And, we studied the healthcare landscape, and validated that our comprehensive Advanced Hemodynamic Management program improves quality and reduces costs for critically ill patients.
As we enter 2015, the team is prepared again to double its customer base globally, and help three times as many patients. We look forward to engaging you in important discussions focused on reducing risk and improving patient care. We look forward to capturing your perspective on our new clinical research targeted to quality and cost. We look forward to sharing the predictive model that our customers have developed to communicate hTEE's economic impact at their executive-level reviews and value analysis committees. We look forward to working with you to implement a whole new Standard of Care.
In 2015, we will accomplish much together.
Until then, my best to you and your families for a joyful holiday season, and a happy, healthy, and prosperous New Year.
With kind regards,